Clearmind Medicine Company Insiders

Clearmind Medicine Management Team Effectiveness

The company has return on total asset (ROA) of (0.5795) % which means that it has lost $0.5795 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (2.679) %, meaning that it created substantial loss on money invested by shareholders. Clearmind Medicine's management efficiency ratios could be used to measure how well Clearmind Medicine manages its routine affairs as well as how well it operates its assets and liabilities. As of December 3, 2024, Return On Tangible Assets is expected to decline to -3.41. The current year's Return On Capital Employed is expected to grow to -13.37. At present, Clearmind Medicine's Total Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Non Current Assets Total is expected to grow to about 224.1 K, whereas Other Current Assets are forecasted to decline to about 106.1 K. The current year's Common Stock Shares Outstanding is expected to grow to about 244.5 K, whereas Net Loss is projected to grow to (8 M).

Clearmind Medicine Workforce Comparison

Clearmind Medicine Common Benchmark Summation

Clearmind Medicine Notable Stakeholders

The success or failure of an entity such as Clearmind Medicine Common often depends on how effective the management is. Clearmind Medicine management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Clearmind management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Clearmind management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of Clearmind Medicine's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Clearmind Medicine's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Clearmind Medicine's management manipulating its earnings.

When running Clearmind Medicine's price analysis, check to measure Clearmind Medicine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Clearmind Medicine is operating at the current time. Most of Clearmind Medicine's value examination focuses on studying past and present price action to predict the probability of Clearmind Medicine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Clearmind Medicine's price. Additionally, you may evaluate how the addition of Clearmind Medicine to your portfolios can decrease your overall portfolio volatility.